Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...
Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...
Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib.
Abbott has announced the company has received approval from the U.S. Food and Drug Administration (FDA) for its Volt PFA ...
PANAMA CITY — A local hospital continues working to provide its patients with up-to-date procedures. According to a press release from Ascension Sacred Heart Bay, the facility now offers pulsed field ...
Dealing with both type 2 diabetes and atrial fibrillation made it twice as difficult for Matt Jewell to live a healthy lifestyle. Medicine to control his abnormal heart rhythm slowed down his heart ...
April 10 (UPI) --Recurrence of atrial fibrillation in patients who have undergone catheter heart ablation may be reduced by treating gum disease within three months of the procedure, new Japanese ...
Catheter ablation significantly reduces cardiovascular risks and mortality in patients with both atrial fibrillation and obstructive sleep apnea. The study involved over 18,000 patients, showing a ...
A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements ...
With symptoms such as a racing, fluttering heartbeat and shortness of breath, atrial fibrillation (AFib) is more than uncomfortable — it makes stroke five times more likely and, over time, can weaken ...
Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique, ...
The efficacy of catheter ablation for heart failure (HF) patients with atrial fibrillation (Afib or AF) hinged on the phenotype of disease, researchers reported based on a meta-analysis. Compared with ...